Skip to Content

What types of MS does Ocrevus treat?

Medically reviewed by Last updated on Sep 10, 2019.

Official Answer


Ocrevus (ocrelizumab) is the first treatment approved for primary progressive multiple sclerosis (PPMS). It is also approved for relapsing forms of multiple sclerosis.

In both forms of MS, Phase III controlled studies demonstrated that Ocrevus slowed disability progression and reduce signs of disease activity in the brain (MRI lesions). In the RMS group, relapses per year were reduced by nearly one-half.

Side effects with Ocrevus were primarily mild to moderate in severity and adverse effect rates were similar to high-dose interferon beta-1a or placebo groups, and included infusion reactions and upper respiratory tract infections.

Related Medical Questions

Drug Information

Related Support Groups